Skip to main content
SERAHealthcare

Sera Prognostics Inc (SERA) Insider Trading

In the last 90 days, 4 Sera Prognostics Inc (SERA) insiders reported no open-market purchases and 6 sales totaling $79,563. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 12, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 12, 2026Tiffany Eul Davis InglisChief Medical OfficerSale8,024$2.03$16,289
Sep 10, 2026Tiffany Eul Davis InglisChief Medical OfficerSale486$2.00$972.00
Sep 10, 2026Dyaarl Lee Anderson Jr.Chief Commercial OfficerSale1,800$2.00$3,600
Sep 10, 2026Zhenya LindgardtChief Executive OfficerSale7,022$2.00$14,044
Sep 10, 2026Benjamin JacksonGeneral CounselSale2,190$2.00$4,380
Sep 8, 2026Zhenya LindgardtChief Executive OfficerSale20,139$2.00$40,278
Jun 11, 2026Tiffany Eul Davis InglisChief Medical OfficerSale362$2.01$727.62
Jun 11, 2026Dyaarl Lee Anderson Jr.Chief Commercial OfficerSale4,739$2.01$9,525
Jun 11, 2026Austin AertsChief Financial OfficerSale2,037$2.01$4,094
Jun 11, 2026Zhenya LindgardtChief Executive OfficerSale6,990$2.01$14,050

Common questions

SERA insider trading FAQ

Are SERA insiders buying or selling?
Over the last 90 days, SERA insiders were net sellers, reporting $0.00 of open-market purchases and $79,563 of sales.
When was the last SERA insider purchase?
No open-market insider purchase of Sera Prognostics Inc stock was reported in the last 90 days.
Where does SERA insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Sera Prognostics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.